Hostname: page-component-78c5997874-v9fdk Total loading time: 0 Render date: 2024-11-20T01:46:45.999Z Has data issue: false hasContentIssue false
  • English
  • Français

Intramuscular olanzapine: efficacy and safety in acutely agitated patients with dementia

Published online by Cambridge University Press:  16 April 2020

M. Karena ,
H. Wang ,
S. David ,
J.R. Wright ,
B. Jones ,
C.M. Beasley Jr. ,
P. Feldman  and
A. Breier
M. Karena
Affiliation:
Eli Lilly and Company, Lilly Research Laboratories, USA
H. Wang
Affiliation:
Eli Lilly and Company, Lilly Research Laboratories, USA
S. David
Affiliation:
Eli Lilly and Company, Lilly Research Laboratories, USA
J.R. Wright
Affiliation:
Eli Lilly and Company, Lilly Research Laboratories, USA
B. Jones
Affiliation:
Eli Lilly and Company, Lilly Research Laboratories, USA
C.M. Beasley Jr.
Affiliation:
Eli Lilly and Company, Lilly Research Laboratories, USA
P. Feldman
Affiliation:
Eli Lilly and Company, Lilly Research Laboratories, USA
A. Breier
Affiliation:
Eli Lilly and Company, Lilly Research Laboratories, USA

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Posters, Sunday, 5 May 2002
Information
European Psychiatry , Volume 17 , Issue S1 , May 2002 , pp. 131s
Copyright
Copyright © Elsevier, Paris 2002
Submit a response

Comments

No Comments have been published for this article.